Cornell Family Donates $10 Million to Sarasota Memorial Behavioral Health Pavilion
SARASOTA, Fla., Oct. 20, 2021 /PRNewswire/ -- The Sarasota Memorial Healthcare Foundation today announced that Target Corp. Chairman and CEO Brian...
Year: 2021
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of...
Chu de Quebec Legal Action Dismissed
TORONTO, ON / ACCESSWIRE / October 20, 2021 / Tree of Knowledge International Corp., ("TOKI") is pleased to announce that...
NeuroMetrix Names Strategic Growth Executive, Susan M. Bell, RN, BN, as Senior Vice President of Population Health & Value Based Care
WOBURN, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Susan M....
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups
Investigator-initiated study shows remission in major depression symptoms for 50% of participants London, UK – 20 October 2021 COMPASS Pathways...
Parexel and Kyoto University Hospital Announce Strategic Alliance
Ki-CONNECT collaboration seeks to offer clinical trial benefits to patients and the pharmaceutical industryBOSTON and DURHAM, N.C., Oct. 20, 2021...
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that...
AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board
Dr. Nichols Strengthens Board with 25 Years of Optometry and Academic ExperienceSAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- AXIM...
eSight Announces Clinical Research Partnership with Ocular Health Centre’s EyeStart Inc.
Collaboration with EyeStart to help develop the next generation of eSight devicesTORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement...
Allied Corp Signs Major Supply Agreement With US Multi State Operator (MSO) and Sales Agreement for Allied’s CBD Brands
KELOWNA, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy
Single AAV intravenous dose achieved widespread CNS distribution and sustained correction of GCase activity in multiple brain regionsCAMBRIDGE, Mass., Oct....
Pure Extracts Ships Repeat Orders of Edible Gummies and Vapes
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Simply Better Brands Corp. Positioning for Significant Growth Fueled by Customer Acquisition, New Distribution and Geographic Expansion
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC)...
Healthy Extracts Launches High-Potency Organic Citrus Bergamot Formulations with Clinically Proven Heart Benefits, Available Exclusively on Amazon
Organic Citrus Bergamot for Women Organic Citrus Bergamot for Women LAS VEGAS, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision...
OliX Pharmaceuticals Enters Agreement with Pharmaron to Advance Non-clinical Toxicology Testing for Hepatitis B Candidate OLX703A
Previous non-clinical pharmacology study demonstrated substantial reduction in serum markers of HBVSUWON, Republic of Korea, Oct. 20, 2021 (GLOBE NEWSWIRE)...
Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021
BOCA RATON, Fla, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
Homology Medicines Announces Presentation of Data Supporting Clinical Programs in MPS II and PKU, including Nonclinical and Patient-Focused Research, at American Society of Human Genetics Meeting
- Oral Presentation on In Vivo Gene Therapy Product Candidate and Data on Gene Editing Candidate Paved Way for Initiation...
CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI
BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer
Study met both primary endpoints in patients with ER+/HER2- advanced or mBCElacestrant becomes the first oral SERD with positive topline...